AxoGen Inc - ESG Rating & Company Profile powered by AI
The ESG score covers 17 UN SDGs including: 'Clean Water & Sanitation', 'Decent Work & Economic Growth' and 'Life below Water'. If you work at AxoGen Inc and you would like to licence your Sustainability aseessment, please get in touch. This page is a zero-cost E,S&G analysis for AxoGen Inc.
AxoGen Inc in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 6.6; made up of an environmental score of 6.4, social score of 5.3 and governance score of 8.0.
6.6
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
84 | Surgical Innovations Group PLC | 6.7 | High |
84 | Scandinavian Real Heart AB | 6.7 | High |
92 | AxoGen Inc | 6.6 | High |
92 | Carefusion Corp | 6.6 | High |
92 | Creo Medical Group PLC | 6.6 | High |
... | ... | ... | |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does AxoGen Inc have an accelerator or VC vehicle to help deliver innovation?
Does AxoGen Inc disclose current and historical energy intensity?
Does AxoGen Inc report the average age of the workforce?
Does AxoGen Inc reference operational or capital allocation in relation to climate change?
Does AxoGen Inc disclose its ethnicity pay gap?
Does AxoGen Inc disclose cybersecurity risks?
Does AxoGen Inc offer flexible work?
Does AxoGen Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does AxoGen Inc disclose the number of employees in R&D functions?
Does AxoGen Inc conduct supply chain audits?
Does AxoGen Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does AxoGen Inc conduct 360 degree staff reviews?
Does AxoGen Inc disclose the individual responsible for D&I?
Does AxoGen Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does AxoGen Inc disclose current and / or historical scope 2 emissions?
Does AxoGen Inc disclose water use targets?
Does AxoGen Inc have careers partnerships with academic institutions?
Did AxoGen Inc have a product recall in the last two years?
Does AxoGen Inc disclose incidents of discrimination?
Does AxoGen Inc allow for Work Councils/Collective Agreements to be formed?
Has AxoGen Inc issued a profit warning in the past 24 months?
Does AxoGen Inc disclose parental leave metrics?
Does AxoGen Inc disclose climate scenario or pathway analysis?
Does AxoGen Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does AxoGen Inc disclose the pay ratio of women to men?
Does AxoGen Inc support suppliers with sustainability related research and development?
Does AxoGen Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does AxoGen Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is AxoGen Inc involved in embryonic stem cell research?
Does AxoGen Inc disclose GHG and Air Emissions intensity?
Does AxoGen Inc disclose its waste policy?
Does AxoGen Inc report according to TCFD requirements?
Does AxoGen Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does AxoGen Inc disclose energy use targets?
Does AxoGen Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does AxoGen Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for AxoGen Inc
These potential risks are based on the size, segment and geographies of the company.
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.